Efficacy and safety of Naoxintong capsule for treating chronic stable angina: study protocol for a randomized controlled trial

Abstract Background Cardiovascular disease is the leading cause of mortality and morbidity worldwide, Chronic stable angina (CSA) is the main symptom of myocardial ischemia, causes increased risk of major cardiovascular events such as sudden cardiac death and myocardial infarction. Naoxintong (NXT)...

Full description

Bibliographic Details
Main Authors: Gao Huanjia, Cai Hairong, Zhuang Jieqin, Dai Xingzhen, Fu Xue, Zhang Weizhang, Chen Bojun
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Trials
Subjects:
Online Access:https://doi.org/10.1186/s13063-021-05264-y